Clinical trial
Post-surgical Pain Care Pathways During Enhanced Recovery Surgery Using Exparel (Bupivacaine Liposome Injectable Suspension) Plus Bupivacaine With Epinephrine Versus Bupivacaine.
NCT03001453 is registered in ClinicalTrials.gov with American Hip Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-surgical Pain Care Pathways During Enhanced Recovery Surgery Using Exparel (Bupivacaine Liposome Injectable Suspension) Plus Bupivacaine With Epinephrine Versus Bupivacaine.
- Lead sponsor
- American Hip Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2014
- Completion date
- March 31, 2016
- Enrollment
- 107 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative